Clinical study of Guipi Decoction on heart failure combined with anemia: a randomized controlled trial.
- Conditions
- heart failure
- Registration Number
- ITMCTR2000003735
- Lead Sponsor
- Shanghai Hospital of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
(1) Other drugs were stable for more than 6 weeks;
(2) NYHA class II-III cardiac function;
(3) The diagnosis standard of anemia was met;
(4) They are 18-70 years old, both male and female;
(5) Those who voluntarily participated in the trial and signed the informed consent.
(1) Late HF, moderate to severe aortic stenosis;
(2) Uncontrolled arterial hypertension;
(3) Patients with acute or chronic infection, advanced liver disease, end-stage chronic kidney disease or malignant disease; (4) Patients with oral iron (> 100mg / day), intravenous iron or erythropoietin, and non HF related anemia (such as hemoglobinopathy) in the past 6 weeks;
(5) Patients with active bleeding or requiring blood transfusion and patients with known iron overload;
(6) Participants in other drug trials within three months before screening;
(7) According to the judgment of the researcher, it is not suitable for the participants.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method